Ibuprofen原料药市场规模、份额及成长分析（按应用、剂型及地区划分）－产业预测（2026-2033）

预计到 2024 年，全球Ibuprofen原料药市场规模将达到 64.6 亿美元，到 2025 年将达到 67.3 亿美元，到 2033 年将达到 93.6 亿美元，预测期（2026-2033 年）的复合年增长率为 4.2%。

由于医疗保健服务的改善、人口老化以及学名药的普及，全球Ibuprofen原料药市场正经历显着增长。处方药和非处方药市场对消炎镇痛药的需求推动了市场扩张。影响这一趋势的关键因素包括全球人口老化、医疗保健服务的改善以及价格低廉的非专利药的日益普及。北美和欧洲占了相当大的市场份额，反映出对高附加价值原料药的稳定需求。然而，原材料成本波动和监管壁垒等挑战可能会影响企业的营运效率。儘管如此，市场前景依然乐观，预计亚太地区将在产能和出口量方面发挥主导作用，从而引领Ibuprofen原料药产业未来的发展趋势。

全球Ibuprofen原料药市场驱动因素

全球Ibuprofen原料药市场正经历显着成长，主要受消费者对经济有效的止痛和抗发炎治疗需求不断增长的推动。专利到期和医疗保健成本节约措施的推动，促进了非专利药的普及，进一步巩固了布洛芬的市场地位。此外，人口老化导致慢性疼痛和发炎性疾病的盛行率不断上升，也对市场规模和收入的成长起到了关键作用。这些因素共同创造了良好的市场环境，有利于Ibuprofen原料药的持续研发与发展，以满足不同消费族群的需求。

限制全球Ibuprofen原料药市场的因素

全球Ibuprofen原料药市场面临许多挑战，其中关键前驱物（如异丁基苯和乙酰氯）价格波动尤其显着。这些价格波动直接影响生产成本和整体盈利，尤其对中小型生产者而言更是如此。此外，对有限供应商的依赖显着增加了供应链风险，导致市场前景难以预测且波动剧烈。这种脆弱性加剧了商业环境的复杂性，使得企业在外部经济压力下难以维持稳定的业务营运和策略规划。

全球Ibuprofen原料药市场趋势

全球Ibuprofen原料药市场正呈现出显着的地域多角化和近岸外包趋势，买家寻求降低供应链风险。这一转变正在重塑市场动态，亚太地区的中小型生产商不断扩大市场份额并提升产能。同时，北美和欧洲市场在日益重视供应安全的背景下，需求也出现了显着復苏。这种不断变化的市场格局不仅影响筹资策略，也加剧了製造商之间的竞争，因为相关人员正在寻求在动盪的市场环境中建立可靠且具韧性的供应链。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 一手和二手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

全球Ibuprofen原料药市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 製药
• 消费者医疗保健
• 动物保健

全球Ibuprofen原料药市场规模（依剂型及复合年增长率划分）（2026-2033 年）

• 药片
• 口服
• 暂停
• 外用药物

全球Ibuprofen原料药市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • GCC
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• BASF股份公司（德国）
• IOL化学製药有限公司（IOLCP）（印度）
• 山东新华药业有限公司（中国）
• Solara Active Pharma Sciences Limited（印度）
• SI集团有限公司（美国）
• 瑞迪博士实验室有限公司（印度）
• 印度颗粒有限公司（印度）
• 美国淄博新华百利高製药有限公司 (中国)
• Strides Pharma Science Limited（印度）
• 梯瓦製药工业股份有限公司（以色列）
• 辉瑞公司（美国）
• 雅培实验室（美国）
• BIOCAUSE公司（美国）
• Mallinckrodt製药公司（美国）
• SMS製药有限公司（印度）
• Wanbury有限公司（印度）
• 奥罗宾多製药有限公司（印度）
• 浙江华海药业股份有限公司（中国）
• Jubilant Life Sciences Ltd.（印度）
• 太阳製药工业有限公司（印度）

结论与建议

Global Ibuprofen API Market size was valued at USD 6.46 Billion in 2024 and is poised to grow from USD 6.73 Billion in 2025 to USD 9.36 Billion by 2033, growing at a CAGR of 4.2% during the forecast period (2026-2033).

The global Ibuprofen API market is experiencing notable growth driven by increased healthcare access, a growing elderly population, and the prevalent use of generic medications. The demand for anti-inflammatory and pain relief medications, both in prescription and over-the-counter segments, is propelling market expansion. Key factors influencing this trend include a worldwide aging demographic, enhanced healthcare accessibility, and greater adoption of affordable generic alternatives. North America and Europe hold significant market shares, reflecting a stable demand for high-value APIs. However, challenges like fluctuating raw material costs and regulatory hurdles may affect operational efficiency. The outlook remains optimistic as Asia Pacific is anticipated to lead in production capacity and export volume, establishing key trends for the Ibuprofen API sector going forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Ibuprofen API market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Ibuprofen API Market Segments Analysis

Global Ibuprofen API Market is segmented by Application, Formulation Type and region. Based on Application, the market is segmented into Pharmaceuticals, Consumer Healthcare and Animal Healthcare. Based on Formulation Type, the market is segmented into Tablets, Oral, Suspension and Topical. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Ibuprofen API Market

The Global Ibuprofen API market is experiencing significant growth driven by the rising demand for cost-effective pain relief and anti-inflammatory treatments. The proliferation of generic formulations, propelled by the expiration of patents and initiatives aimed at improving healthcare affordability, further strengthens market presence. Additionally, the aging population coupled with a higher prevalence of chronic pain conditions and inflammatory disorders is playing a crucial role in expanding the market's size and revenue. Together, these factors create a robust environment for the continuous development and advancement of Ibuprofen API offerings, meeting the needs of diverse consumer segments.

Restraints in the Global Ibuprofen API Market

The Global Ibuprofen API market faces significant challenges due to the volatility in the prices of essential precursors such as isobutyl benzene and acetyl chloride. These price fluctuations directly impact production costs and the overall profitability for manufacturers, particularly smaller and medium-sized enterprises. Furthermore, the market's reliance on a narrow range of suppliers poses considerable supply chain risks, leading to an unpredictable and unstable outlook. This vulnerability complicates the business environment, making it difficult for companies to maintain consistent operations and strategic planning in the face of external economic pressures.

Market Trends of the Global Ibuprofen API Market

The Global Ibuprofen API market is witnessing a significant trend towards regional diversification and near-shoring as buyers aim to mitigate supply chain risks. This shift is reshaping market dynamics, with small to mid-sized producers in the Asia-Pacific region boosting their presence and expanding production capabilities. Concurrently, there is a noticeable demand resurgence in North America and Europe, driven by the growing emphasis on security of supply. This evolving landscape not only influences sourcing strategies but also encourages greater competition among manufacturers, as stakeholders seek reliable and resilient supply chains in an increasingly volatile market environment.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Ibuprofen API Market Size by Application & CAGR (2026-2033)

• Market Overview
• Pharmaceuticals
• Consumer Healthcare
• Animal Healthcare

Global Ibuprofen API Market Size by Formulation Type & CAGR (2026-2033)

• Market Overview
• Tablets
• Oral
• Suspension
• Topical

Global Ibuprofen API Market Size & CAGR (2026-2033)

• North America (Application, Formulation Type)
  • US
  • Canada
• Europe (Application, Formulation Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Application, Formulation Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Application, Formulation Type)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Application, Formulation Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• BASF SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IOL Chemicals and Pharmaceuticals Limited (IOLCP) (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shandong Xinhua Pharmaceutical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Solara Active Pharma Sciences Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SI Group, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Granules India Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Strides Pharma Science Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIOCAUSE Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mallinckrodt Pharmaceuticals (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SMS Pharmaceuticals Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wanbury Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aurobindo Pharma Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zhejiang Huahai Pharmaceutical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jubilant Life Sciences Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations